Q9MYZ9
Gene name |
EPOR |
Protein name |
Erythropoietin receptor |
Names |
TR, TfR, TfR1, Trfr, EPO-R |
Species |
Sus scrofa (Pig) |
KEGG Pathway |
ssc:397554 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9MYZ9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9MYZ9-F1 | Predicted | AlphaFoldDB |
5 variants for Q9MYZ9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs790765758 | 20 | A>S | No | EVA | |
| rs321721168 | 92 | H>R | No | EVA | |
| rs787672563 | 136 | R>L | No | EVA | |
| rs706999943 | 300 | T>N | No | EVA | |
| rs697020881 | 438 | R>H | No | EVA |
No associated diseases with Q9MYZ9
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| external side of plasma membrane | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| nuclear speck | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| cytokine receptor activity | Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| erythropoietin receptor activity | Combining with erythropoietin and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| identical protein binding | Binding to an identical protein or proteins. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| brain development | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
| cytokine-mediated signaling pathway | The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
| decidualization | The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta. |
| heart development | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
| hemopoiesis | The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates. |
| positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MYHFGATLWP | GVGSLCLLLA | GATWAPSPNS | PDAKFESKAA | LLAARGPEEL | LCFTERLEDL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VCFWEEAGSA | GVGPEDYSFS | YQLEGEPWKP | CHLHQGPTAR | GSVRFWCSLP | TADTSSFVPL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| ELRVTEVSSG | APRYHRIIHI | NEVVLLDPPA | GLLARRAEES | GHVVLRWLPP | PGAPMASLIR |
| 190 | 200 | 210 | 220 | 230 | 240 |
| YEVNISTENA | AGGVQRVEIL | DGRTECVLSN | LRGGTRYTFM | VRARMAEPSF | GGFWSAWSEP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ASLLTASDLD | PLILTLSLIL | VLILLLLAVL | ALLSHRRTLK | QKIWPGIPSP | EGEFEGLFTT |
| 310 | 320 | 330 | 340 | 350 | 360 |
| HKGNFQLWLY | QTDGCLWWSP | CTPFAEDPPA | PLEVLSERCW | GVTQAVEPAA | DDEGSLLEPV |
| 370 | 380 | 390 | 400 | 410 | 420 |
| GSEHARDTYL | VLDKWLLPRR | PASEDLPQPG | GDLDMAAMDE | ASEASFCSSA | LALKPGPEGA |
| 430 | 440 | 450 | 460 | 470 | 480 |
| SAASFEYTIL | DPSSQLLRPR | ALPAELPPTP | PHLKYLYLVV | SDSGISTDYS | SGGSQETQGG |
| 490 | 500 | ||||
| SSSGPYSNPY | ENSLVPAPEP | SPPNYVTCS |